Conagen’s Novel Non-GMO Human Milk Oligosaccharide Paves the Way for Advancing Nutrition in Next Generation Infant Formulas

Bedford, Mass., Aug. 19 (Korea Bizwire) – Conagen, a rapidly-growing Boston-based biotechnology firm, has established a novel and proprietary process for the scalable production of a non-GMO human milk oligosaccharide (HMO), an important nutritional compound only found in human milk. This micronutrition breakthrough will enable the creation of high-quality and cost-effective next generation infant formula products [...]